Drug reaction with eosinophilia and systemic symptoms: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
== Background == |
== Background == |
||
*T-cell mediated |
*T-cell mediated [[severe cutaneous adverse reaction]] |
||
== Clinical Manifestations == |
== Clinical Manifestations == |
||
*Prodrome of fever, malaise, sore throat, dysphagia, pruritus, and a burning sensation on the skin, followed by rash |
|||
* |
*Symptoms include [[fever]], facial edema (which can cause new oblique earlobe creases), [[maculopapular rash]], [[lymphadenopathy]], [[eosinophilia]], [[atypical lymphocytosis]] (earliest and most common hematologic finding), and multiorgan dysfunction |
||
**Includes [[hepatitis]], [[glomerulonephritis]], [[arthritis]], [[pneumonitis]], and [[carditis]] |
**Includes [[hepatitis]] (most common organ after skin), [[glomerulonephritis]], [[arthritis]], [[pneumonitis]], and [[carditis]] |
||
*Rash is typically morbilliform and spreads to involve more than 50% total body surface area |
|||
**Lesions can be urticarial, eczematous, lichenoid, exfoliative, erythrodermic, targetoid, purpuric, vesicular, pustular, alone or in combination |
|||
**About half have mild mucosal involvement |
|||
*Typical onset 2 to 8 weeks after starting medication |
*Typical onset 2 to 8 weeks after starting medication |
||
*Commonly-associated medications: |
*Commonly-associated medications: |
||
**Antibiotics |
**Antibiotics |
||
***[[Vancomycin]]-associated DRESS is more common in European descendants, with the HLA-A*32:01 allele |
***[[Vancomycin]]-associated DRESS is more common in European descendants, with the HLA-A*32:01 allele |
||
***[[Trimethoprim-sulfamethoxazole]] |
|||
**[[Antiepileptic]] medications |
**[[Antiepileptic]] medications: [[lamotrigine]] and [[carbamazepine]] |
||
**[[Allopurinol]] |
**[[Allopurinol]] |
||
*High mortality around |
*High mortality around 5% |
||
== DRESS Scoring System == |
== DRESS Scoring System == |
||
Line 49: | Line 54: | ||
| |
| |
||
|- |
|- |
||
|Eosinophils (if WBC ≥4), or |
|—Eosinophils (if WBC ≥4), or |
||
| |
| |
||
| |
| |
||
Line 56: | Line 61: | ||
| |
| |
||
|- |
|- |
||
|Eosinophils (if WBC <4) |
|—Eosinophils (if WBC <4) |
||
| |
| |
||
| |
| |
||
Line 77: | Line 82: | ||
| |
| |
||
|- |
|- |
||
|Skin rash (%BSA) |
|—Skin rash (%BSA) |
||
| |
| |
||
|No/U |
|No/U |
||
Line 84: | Line 89: | ||
| |
| |
||
|- |
|- |
||
|Skin rash suggesting DRESS |
|—Skin rash suggesting DRESS |
||
|No |
|No |
||
|U |
|U |
||
Line 91: | Line 96: | ||
|≥2 of: purpuric lesions (other than legs), infiltration, facial edema, psoriasiform desquamation |
|≥2 of: purpuric lesions (other than legs), infiltration, facial edema, psoriasiform desquamation |
||
|- |
|- |
||
|Biopsy suggesting DRESS |
|—Biopsy suggesting DRESS |
||
|No |
|No |
||
|Yes/U |
|Yes/U |
||
Line 105: | Line 110: | ||
| |
| |
||
|- |
|- |
||
|Liver involvement |
|—Liver involvement |
||
| |
| |
||
|No/U |
|No/U |
||
Line 112: | Line 117: | ||
| rowspan="5" |Maximum score of 2 |
| rowspan="5" |Maximum score of 2 |
||
|- |
|- |
||
|Kidney involvement |
|—Kidney involvement |
||
| |
| |
||
|No/U |
|No/U |
||
Line 118: | Line 123: | ||
| |
| |
||
|- |
|- |
||
|Muscle or heart involvement |
|—Muscle or heart involvement |
||
| |
| |
||
|No/U |
|No/U |
||
Line 124: | Line 129: | ||
| |
| |
||
|- |
|- |
||
|Pancreas involvement |
|—Pancreas involvement |
||
| |
| |
||
|No/U |
|No/U |
||
Line 130: | Line 135: | ||
| |
| |
||
|- |
|- |
||
|Other organ involvement |
|—Other organ involvement |
||
| |
| |
||
|No/U |
|No/U |
||
Line 148: | Line 153: | ||
|Yes |
|Yes |
||
| |
| |
||
|at least 3 tests were done and negative: HAV, HBV, HCV, ANA, blood cultures, Mycoplasma, Chlamydia |
|at least 3 tests were done and negative: [[HAV]], [[HBV]], [[HCV]], [[ANA]], blood cultures, [[Mycoplasma]], [[Chlamydia]] |
||
|} |
|} |
||
Line 168: | Line 173: | ||
|≤1 |
|≤1 |
||
|} |
|} |
||
== Management == |
|||
* Cessation of offending medication |
|||
* Most common treatment is [[prednisone]] 0.5 to 1 mg/kg (or equivalent glucocorticoid), tapered over 6 to 12 weeks once there is clinical improvement |
|||
** No strong evidence to support this practice |
|||
* If no improvement with prednisone at regular doses, can consider pulse steroids for 3 days |
|||
* People have also tried [[IVIG]], [[Mycobacterium]], [[cyclosporine]], [[cyclophosphamide]], and several biologics (anti-IL5, anti-CD20, JAK inhibitors) |
|||
* Resolution is slow, and can recur or relapse, and some patients are left with chronic complications |
|||
== Further Reading == |
== Further Reading == |
||
* The DRESS Syndrome: A Literature Review. ''Am J Med''. 2011;124(7):588-597. doi: [https://doi.org/10.1016/j.amjmed.2011.01.017 10.1016/j.amjmed.2011.01.017] |
* The DRESS Syndrome: A Literature Review. ''Am J Med''. 2011;124(7):588-597. doi: [https://doi.org/10.1016/j.amjmed.2011.01.017 10.1016/j.amjmed.2011.01.017] |
||
* Drug Reaction with Eosinophilia and Systemic Symptoms. ''NEJM''. 2024. Doi: [https://doi.org/10.1056/NEJMra2204547 10.1056/NEJMra2204547] |
|||
[[Category:Adverse drug reactions]] |
[[Category:Adverse drug reactions]] |
Latest revision as of 20:35, 17 December 2024
Background
- T-cell mediated severe cutaneous adverse reaction
Clinical Manifestations
- Prodrome of fever, malaise, sore throat, dysphagia, pruritus, and a burning sensation on the skin, followed by rash
- Symptoms include fever, facial edema (which can cause new oblique earlobe creases), maculopapular rash, lymphadenopathy, eosinophilia, atypical lymphocytosis (earliest and most common hematologic finding), and multiorgan dysfunction
- Includes hepatitis (most common organ after skin), glomerulonephritis, arthritis, pneumonitis, and carditis
- Rash is typically morbilliform and spreads to involve more than 50% total body surface area
- Lesions can be urticarial, eczematous, lichenoid, exfoliative, erythrodermic, targetoid, purpuric, vesicular, pustular, alone or in combination
- About half have mild mucosal involvement
- Typical onset 2 to 8 weeks after starting medication
- Commonly-associated medications:
- Antibiotics
- Vancomycin-associated DRESS is more common in European descendants, with the HLA-A*32:01 allele
- Trimethoprim-sulfamethoxazole
- Antiepileptic medications: lamotrigine and carbamazepine
- Allopurinol
- Antibiotics
- High mortality around 5%
DRESS Scoring System
- Developed for RegiSCAR, though I can't seem to find a primary reference
Criteria
Criterion | -1 | 0 | 1 | 2 | Notes |
---|---|---|---|---|---|
Fever ≥38.5ºC | No/U | Yes | |||
Enlarged lymph nodes | No/U | Yes | >1 cm in ≥2 areas | ||
Eosinophilia | |||||
—Eosinophils (if WBC ≥4), or | 0.7-1.49 | ≥1.5 | |||
—Eosinophils (if WBC <4) | 10-19.9% | ≥20% | |||
Atypical lymphocytes | No/U | Yes | |||
Rash | |||||
—Skin rash (%BSA) | No/U | >50% | |||
—Skin rash suggesting DRESS | No | U | Yes | ≥2 of: purpuric lesions (other than legs), infiltration, facial edema, psoriasiform desquamation | |
—Biopsy suggesting DRESS | No | Yes/U | |||
Organ involvement | |||||
—Liver involvement | No/U | Yes | Maximum score of 2 | ||
—Kidney involvement | No/U | Yes | |||
—Muscle or heart involvement | No/U | Yes | |||
—Pancreas involvement | No/U | Yes | |||
—Other organ involvement | No/U | Yes | |||
Resolution ≥15 days | No/U | Yes | |||
Exclusion of other causes | Yes | at least 3 tests were done and negative: HAV, HBV, HCV, ANA, blood cultures, Mycoplasma, Chlamydia |
Interpretation
Interpretation | Points |
---|---|
Definite | ≥6 |
Probable | 4-5 |
Possible | 2-3 |
Not DRESS | ≤1 |
Management
- Cessation of offending medication
- Most common treatment is prednisone 0.5 to 1 mg/kg (or equivalent glucocorticoid), tapered over 6 to 12 weeks once there is clinical improvement
- No strong evidence to support this practice
- If no improvement with prednisone at regular doses, can consider pulse steroids for 3 days
- People have also tried IVIG, Mycobacterium, cyclosporine, cyclophosphamide, and several biologics (anti-IL5, anti-CD20, JAK inhibitors)
- Resolution is slow, and can recur or relapse, and some patients are left with chronic complications
Further Reading
- The DRESS Syndrome: A Literature Review. Am J Med. 2011;124(7):588-597. doi: 10.1016/j.amjmed.2011.01.017
- Drug Reaction with Eosinophilia and Systemic Symptoms. NEJM. 2024. Doi: 10.1056/NEJMra2204547